Meadow Creek Investment Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $469K | Buy |
10,516
+4,202
| +67% | +$187K | 0.01% | 743 |
|
|
2019
Q2 | $261K | Buy |
6,314
+990
| +19% | +$40.9K | 0.01% | 947 |
|
|
2019
Q1 | $215K | Buy |
5,324
+1,122
| +27% | +$45.3K | ﹤0.01% | 990 |
|
|
2018
Q4 | $160K | Sell |
4,202
-8,316
| -66% | -$317K | ﹤0.01% | 1033 |
|
|
2018
Q3 | $495K | Hold |
12,518
| – | – | 0.01% | 728 |
|
|
2018
Q2 | $440K | Buy |
12,518
+704
| +6% | +$24.7K | 0.01% | 695 |
|
|
2018
Q1 | $413K | Hold |
11,814
| – | – | 0.01% | 719 |
|
|
2017
Q4 | $410K | Hold |
11,814
| – | – | 0.01% | 731 |
|
|
2017
Q3 | $400K | Hold |
11,814
| – | – | 0.01% | 675 |
|
|
2017
Q2 | $403K | Hold |
11,814
| – | – | 0.01% | 653 |
|
|
2017
Q1 | $368K | Hold |
11,814
| – | – | 0.01% | 620 |
|
|
2016
Q4 | $323K | Buy |
+11,814
| New | +$323K | 0.01% | 612 |
|